Cell fusion as a link between the SARS-CoV-2 spike protein, COVID-19 complications, and vaccine side effects.
| Autor: | Lazebnik Y; Lerna Consulting, New Haven, CT 06511, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Oncotarget [Oncotarget] 2021 Dec 07; Vol. 12 (25), pp. 2476-2488. Date of Electronic Publication: 2021 Dec 07 (Print Publication: 2021). |
| DOI: | 10.18632/oncotarget.28088 |
| Abstrakt: | A distinctive feature of the SARS-CoV-2 spike protein is its ability to efficiently fuse cells, thus producing syncytia found in COVID-19 patients. This commentary proposes how this ability enables spike to cause COVID-19 complications as well as side effects of COVID-19 vaccines, and suggests how these effects can be prevented. Competing Interests: CONFLICTS OF INTEREST Author have no conflicts of interest to declare. (Copyright: © 2021 Lazebnik.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|